Skip to content
Back to Blog
Bio
2025-12-2110 min read5

Complete Guide to Government R&D Support Programs for Bio Companies

A thorough overview of government-funded R&D support programs available for biotechnology and pharmaceutical companies in Korea.

KITIM Consulting Team

Complete Guide to Government R&D Support Programs for Bio Companies

Korea's government has identified biotechnology as a strategic growth industry, allocating a combined R&D budget of approximately KRW 3 trillion across multiple ministries. This multi-ministry approach creates a rich landscape of funding opportunities for bio companies, but navigating the various programs can be challenging.

Overview of the Bio R&D Landscape

  • Total government bio R&D budget: Approximately KRW 3 trillion annually across all ministries
  • Key ministries: Ministry of Health and Welfare (MOHW), Ministry of Science and ICT (MSIT), Ministry of Trade, Industry and Energy (MOTIE), and Ministry of SMEs and Startups (MSS)
  • Focus areas: New drug development, medical devices, digital health, biosimilars, cell and gene therapy, and bio-manufacturing
  • Funding types: Grants, matching funds, and subsidized loans tailored to different stages of company development
  • The Korean government's multi-ministry approach means that bio companies may find relevant programs across several agencies. Understanding which ministry and program best aligns with your technology and development stage is critical.

    Key Programs

  • Bio-Medical Technology Development Program (MOHW/KHIDI): Large-scale R&D grants for drug discovery, preclinical development, and clinical trials, with project budgets ranging from KRW 500 million to KRW 5 billion
  • KHIDI Health Industry R&D Programs: Targeted support for health industry innovation including medical devices, digital therapeutics, and health data platforms
  • MSS Bio-Specific Tracks: Programs designed for bio SMEs and startups, including the TIPS Bio Track, Startup Growth Technology Development, and Innovation Voucher programs
  • MOTIE Industrial Technology Innovation: Support for bio-manufacturing technology, materials development, and commercialization-stage projects
  • MSIT Basic Research Programs: Funding for early-stage fundamental research in life sciences and convergence technologies
  • Eligibility and Requirements

  • Bio SME criteria: Companies must be classified as SMEs under the SME Basic Act with bio-related business registration codes
  • Research personnel: Most programs require a minimum number of dedicated research staff, typically at least two to three full-time researchers
  • Financial standing: Applicants must demonstrate adequate financial health, including positive net assets and no tax delinquency
  • Technology readiness: Different programs target specific Technology Readiness Levels (TRLs), from basic research (TRL 1-3) to commercialization (TRL 7-9)
  • Application Strategy

    Technology readiness level matching is arguably the most important strategic decision. Applying to a program mismatched with your current TRL is a leading cause of rejection. Consider these approaches:

  • Map your technology to the appropriate TRL and select programs that align with your development stage
  • Build consortia with universities, research institutes, or complementary companies to strengthen applications
  • Demonstrate clear differentiation from existing technologies in the same therapeutic or product area
  • Prepare a realistic timeline with well-defined milestones that match the program's evaluation criteria
  • Maximizing Your Success Rate

    To stand out among the hundreds of applications each program receives, focus on these key areas:

  • IP portfolio: Strong patent filings or granted patents significantly boost your application score, demonstrating both innovation and commercial potential
  • Preliminary data: Even early-stage programs value applicants who can show proof-of-concept data or published research supporting their approach
  • Clinical development plan: For therapeutic programs, a well-structured clinical plan showing awareness of regulatory requirements demonstrates readiness
  • Team credibility: Highlight team members' relevant experience, publications, and track records in bio R&D
  • Commercialization pathway: Articulate a clear path from R&D results to market, including target markets, competitive analysis, and revenue projections
  • How KITIM Can Help

    KITIM's consulting team specializes in government R&D program applications for bio companies. We provide program selection guidance, proposal writing support, consortium building assistance, and post-selection project management consulting. Our track record includes successful applications across all major ministry programs. Contact us for a free initial consultation.

    Government R&DBio Support ProgramsResearch & Development
    매일 자동 업데이트

    이 분야 정부지원사업, AI가 찾아드립니다

    3분 기업진단만 완료하면 귀사에 맞는 공고를 적합도 점수와 함께 추천합니다. 무료입니다.

    AI 맞춤 공고 무료로 받기

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.